Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 154.22% | 97.18% | 171.77% | 34.82% | 783.73% |
| Total Depreciation and Amortization | 59.52% | 83.02% | 113.08% | 157.99% | 182.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.74% | -59.81% | -58.31% | 32.47% | 36.79% |
| Change in Net Operating Assets | 51.60% | 25.06% | -131.72% | 5.43% | -1.96% |
| Cash from Operations | 33.74% | 19.05% | -10.19% | 70.67% | 295.61% |
| Capital Expenditure | -23.25% | -11.12% | 1.59% | 13.11% | 17.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 140.06% | 186.95% | 181.01% | 131.51% | 91.96% |
| Cash from Investing | 42.32% | 112.35% | 118.96% | 113.82% | 82.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -79.88% | -72.93% | -47.38% | -56.87% | 32.79% |
| Repurchase of Common Stock | 35.58% | 35.02% | -147.07% | -851.14% | -794.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.27% | 26.79% | -250.14% | -2,790.42% | -11,737.98% |
| Foreign Exchange rate Adjustments | 61.36% | 63.46% | -162.71% | -177.61% | 31.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.69% | 137.07% | -28.12% | 80.99% | 70.93% |